179 related articles for article (PubMed ID: 7227210)
1. [Bromocriptine induced cystic tumour regression in advanced prolactinomas (author's transl)].
Galvan G; Frick J; Irnberger T
Dtsch Med Wochenschr; 1981 May; 106(20):637-42. PubMed ID: 7227210
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of prolactin-secreting pituitary tumors with bromocriptine].
Katzir D; Rosenberg T; Ramot Y; Gaver-Shavit A; Gilboa Y
Harefuah; 1990 Feb; 118(3):141-5. PubMed ID: 2341064
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and drug therapy of prolactinoma.
Ciccarelli E; Camanni F
Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
[TBL] [Abstract][Full Text] [Related]
4. Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size.
van 't Verlaat JW; Croughs RJ
Clin Endocrinol (Oxf); 1991 Mar; 34(3):175-8. PubMed ID: 2036725
[TBL] [Abstract][Full Text] [Related]
5. Extrasellar prolactinomas: successful management of 24 patients using bromocriptine.
Sieck JO; Niles NL; Jinkins JR; Al-Mefty O; el-Akkad S; Woodhouse N
Horm Res; 1986; 23(3):167-76. PubMed ID: 3949288
[TBL] [Abstract][Full Text] [Related]
6. [Bromocriptine therapy of prolactinoma and hyperprolactinemia].
Wu JZ
Zhonghua Nei Ke Za Zhi; 1983 Oct; 22(10):611-4. PubMed ID: 6673930
[No Abstract] [Full Text] [Related]
7. [Bromocriptine treatment of prolactinomas and primary hyperprolactinemia (author's transl)].
Fossati P; Grenier JL; Stevenard C; Fermon C; Christiaens JL; Linquette M
Ann Med Interne (Paris); 1982; 133(1):45-7. PubMed ID: 7065588
[TBL] [Abstract][Full Text] [Related]
8. Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 cases.
Beckers A; Petrossians P; Abs R; Flandroy P; Stadnik T; de Longueville M; Lancranjan I; Stevenaert A
J Clin Endocrinol Metab; 1992 Jul; 75(1):275-80. PubMed ID: 1619019
[TBL] [Abstract][Full Text] [Related]
9. [Immediate efficacy of bromocriptine (BrC)-LAR in the treatment of macroprolactinomas: apropos of a case].
García Calzado MC; Ruiz Buendía A
Rev Clin Esp; 1992 Jun; 191(2):112-3. PubMed ID: 1502384
[No Abstract] [Full Text] [Related]
10. [Pathological changes of prolactinomas treated with bromocriptine].
Teramoto A; Takakura K; Fukushima T; Osamura Y
No Shinkei Geka; 1982 Jun; 10(6):619-27. PubMed ID: 7121729
[TBL] [Abstract][Full Text] [Related]
11. Giant invasive prolactinoma: a case report and review of nine further cases.
Davis JR; Sheppard MC; Heath DA
Q J Med; 1990 Mar; 74(275):227-38. PubMed ID: 2385731
[TBL] [Abstract][Full Text] [Related]
12. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
[TBL] [Abstract][Full Text] [Related]
13. Long-acting bromocriptine for the acute treatment of large macroprolactinomas.
Zarate A; Moran C; Miranda R; Loyo M; Medina M; Fonseca ME
J Endocrinol Invest; 1987 Jun; 10(3):233-6. PubMed ID: 3624799
[TBL] [Abstract][Full Text] [Related]
14. [Bromocriptine therapy in macroprolactinomas with extrasellar extension].
Díaz de Greñu Martínez C; Menéndez Torre EL; Boix Pallarés P; Díaz Cadorniga FJ; Aller Granda J; Rabal Artal A
Med Clin (Barc); 1988 Jan; 90(4):148-50. PubMed ID: 3352347
[No Abstract] [Full Text] [Related]
15. [Results of bromocriptine treatment of giant or invasive prolactin adenomas. Apropos of 20 cases].
Scherrer H; Turpin G; De Gennes JL; Schaison-Cusin M; Heshmati HM; Thibierge M; Metzger J
Ann Med Interne (Paris); 1985; 136(6):459-66. PubMed ID: 4083636
[TBL] [Abstract][Full Text] [Related]
16. Effect of the new dopaminergic agonist CV 205-502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas.
Duranteau L; Chanson P; Lavoinne A; Horlait S; Lubetzki J; Kuhn JM
Clin Endocrinol (Oxf); 1991 Jan; 34(1):25-9. PubMed ID: 1672268
[TBL] [Abstract][Full Text] [Related]
17. Rapid resolution of visual field defects and reduction in macroprolactinoma size with bromocriptine therapy. A case report.
Kahn SE; Miller JL
S Afr Med J; 1982 Oct; 62(19):696-9. PubMed ID: 7135127
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor effect of bromocriptine in 5 cases of invasive prolactinoma].
Guibout M; Jaquet P; Grisoli F; Tapias PL; Mouly A
Ann Med Interne (Paris); 1982; 133(1):48-50. PubMed ID: 7065589
[No Abstract] [Full Text] [Related]
19. Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies.
Ahmed M; al-Dossary E; Woodhouse NJ
Fertil Steril; 1992 Sep; 58(3):492-7. PubMed ID: 1521641
[TBL] [Abstract][Full Text] [Related]
20. Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report.
Clayton RN; Webb J; Heath DA; Dunn PJ; Rolfe EB; Hockley AD
Clin Endocrinol (Oxf); 1985 May; 22(5):573-81. PubMed ID: 4028456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
